New drug reimbursement list comes into force

…– the active substances risperidone, sulpiride, aripiprazole, ziprasidone and topiramate were granted reimbursement status for off-label use in Tourette’s syndrome. Furthermore, amantadine was granted off-label reimbursement status – for the treatment of dyskinesia in adults.

Sign up now to open the entire news item.

You are allowed to open only one news item from PMR websites.
  • 1E-mail
    (to send requested information)
  • 2Brief profile
    (required for new e-mails only)

 required fields

You must accept PMR’s Privacy Policy.